首页 › 基金 › a16z Capital Management, L.L.C. › CAMP
a16z Capital Management, L.L.C. 对 CAMP 的持仓历史
CAMP4 THERAPEUTICS CORP · 医疗保健
a16z Capital Management, L.L.C. 在 Q3 2026 的 13F 申报中披露持有 CAMP(CAMP4 THERAPEUTICS CORP)2,125,339 股,市值约 US$8.6M,约占其申报组合的 0.04%,在其申报持仓中市值排名第 14 位。 a16z Capital Management, L.L.C. 最近 8 个申报季度中有 8 个季度披露了 CAMP 持仓,最早可追溯至 Q4 2024。
最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR
a16z Capital Management, L.L.C. 对 CAMP 的持仓演变
a16z Capital Management, L.L.C. 于 Q4 2024 首次披露 CAMP 持仓:2,125,339 股(约 US$11.1M)。 该持仓在 Q4 2025 达到峰值 2,125,339 股,市值约 US$13.0M。 在 8 次申报中,a16z Capital Management, L.L.C. 的持股数量始终未变。 最近一期申报(Q3 2026)显示持股 2,125,339 股、市值约 US$8.6M。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q4 2024 | 2.13M | $11.09M | 新进 |
| Q1 2025 | 2.13M | $8.50M | 持有 |
| Q2 2025 | 2.13M | $3.08M | 持有 |
| Q3 2025 | 2.13M | $6.38M | 持有 |
| Q4 2025 | 2.13M | $13.03M | 持有 |
| Q1 2026 | 2.13M | $9.37M | 持有 |
| Q2 2026 | 2.13M | $9.29M | 持有 |
| Q3 2026 | 2.13M | $8.59M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 CAMP 与 13F 数据
CAMP(CAMP4 THERAPEUTICS CORP)属于医疗保健行业。我们追踪的基金中还有 38 只申报持有 CAMP,申报仓位最大的包括:Vivo Capital, LLC (US$22.6M), 5AM Venture Management, LLC (US$21.3M), Trails Edge Capital Partners, LP (US$14.6M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 CAMP 的基金
- Vivo Capital, LLC 5.58M 股 · $22.56M · Q3 2026
- 5AM Venture Management, LLC 5.28M 股 · $21.32M · Q3 2026
- Trails Edge Capital Partners, LP 3.63M 股 · $14.65M · Q3 2026
- Stonepine Capital Management, LLC 2.79M 股 · $11.26M · Q3 2026
- HARBOURVEST PARTNERS LLC 1.27M 股 · $5.14M · Q3 2026
- Enavate Sciences GP, LLC 1.04M 股 · $4.21M · Q3 2026
- Birchview Capital, LP 120.00K 股 · $484.80K · Q3 2026
更多关于 a16z Capital Management, L.L.C.
常见问题
How long has a16z Capital Management, L.L.C. held CAMP?
a16z Capital Management, L.L.C. has disclosed CAMP holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
What is a16z Capital Management, L.L.C.'s current position in CAMP?
As of Q3 2026, a16z Capital Management, L.L.C. holds 2.13M shares of CAMP (CAMP4 THERAPEUTICS CORP), valued at $8.59M, representing 0.04% of its reported portfolio and ranking #14.
Has a16z Capital Management, L.L.C. been buying or selling CAMP?
In the latest 13F filing (Q3 2026), a16z Capital Management, L.L.C. held unchanged its position in CAMP. The position peaked in Q4 2025 at 2.13M shares.
Which other funds hold CAMP?
Other major institutional holders of CAMP include Vivo Capital, LLC, 5AM Venture Management, LLC, Trails Edge Capital Partners, LP, among 38 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.